Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy.
Colorectal cancer is the third leading cause of cancer-related death in the western world. In vitro and in vivo experiments showed that omega-3 polyunsaturated fatty acids (n-3 PUFAs) can attenuate the proliferation of cancer cells, including colon cancer, and increase the efficacy of various antica...
Main Authors: | Flavia De Carlo, Theodore R Witte, W Elaine Hardman, Pier Paolo Claudio |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3713061?pdf=render |
Similar Items
-
DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies
by: Diana Cervantes-Madrid, et al.
Published: (2017-03-01) -
RBC and WBC fatty acid composition following consumption of an omega 3 supplement: Lessons for future clinical trials
by: Ballester Oscar F, et al.
Published: (2010-03-01) -
Characteristics of CD133 Human Colon Cancer SW620 Cells
by: Hironobu Kawamoto M.D., Ph.D., et al.
Published: (2010-06-01) -
Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells.
by: Lin Cui, et al.
Published: (2010-08-01) -
The {omega}-3 fatty acid eicosapentaenoic acid elicits cAMP generation in colonic epithelial cells via a "store-operated" mechanism.
by: Roy, J, et al.
Published: (2010)